Skip to main content

Alport Syndrome

  • Chapter
  • First Online:
  • 2298 Accesses

Abstract

A.K. was a 5-year-old boy who presented to the ­pediatric nephrology clinic with a recent finding of microscopic hematuria and proteinuria on routine screening. The analysis was repeated two weeks later with persistence of hematuria and proteinuria. A complete blood count (CBC) and a metabolic panel (Chem-7) were both normal. Renal ultrasound was performed which was also normal and without hydronephrosis. A.K. had one younger brother who was two years old with no health problems. A.K.’s father was 38 years old and had no health concerns. A.K.’s father’s brother, sister, and parents were all healthy, with no renal concerns. A.K.’s father’s brother had one son who was healthy at seven years. A.K.’s mother was healthy at 37 years. She had one brother and two sisters, none of whom had any renal concerns. One of her sisters had a son and a daughter; the son, who was six years old, had proteinuria found on dipstick about a year ago, but he has not been referred to a nephrologist. A.K.’s maternal grandfather was healthy and his grandmother died of myocardial infarction at the age of 60.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Barker DF, Pruchno CJ, Jiang X et al (1996) A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet 58:1157–1165

    PubMed  CAS  PubMed Central  Google Scholar 

  2. Kashtan CE (2008) Collagen IV-related nephropathies (Alport syndrome and thin basement membrane nephropathy). Gene Reviews. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=alport. Accessed 14 Apr 2010

  3. Renieri A, Meroni M, Sessa A et al (1994) Variability of clinical phenotype in a large Alport family with Gly 1143 Ser change of collagen alpha 5(IV)-chain. Nephron 67:444–449

    Article  PubMed  CAS  Google Scholar 

  4. Hertz JM (2009) Alport syndrome. Molecular genetic aspects. Dan Med Bull 56:105–152

    PubMed  Google Scholar 

  5. Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422–433

    Article  PubMed  CAS  Google Scholar 

  6. Hudson BG, Reeders ST, Tryggvason K (1993) Type IV collagen: structure, gene organization, and role in human ­diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 268:26033–26036

    PubMed  CAS  Google Scholar 

  7. Jais JP, Knebelmann B, Giatras I et al (2000) X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11:649–657

    PubMed  CAS  Google Scholar 

  8. Gross O, Netzer KO, Lambrecht R et al (2002) Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant 17:1218–1227

    Article  PubMed  Google Scholar 

  9. Quigley R (2008) Evaluation of hematuria and proteinuria: how should a pediatrician proceed? Curr Opin Pediatr 20:140–144

    Article  PubMed  Google Scholar 

  10. Lee YM, Baek SY, Kim JH et al (2006) Analysis of renal biopsies performed in children with abnormal findings in urinary mass screening. Acta Paediatr 95:849–853

    Article  PubMed  Google Scholar 

  11. Wittwer CT (2009) High-resolution DNA melting analysis: advancements and limitations. Hum Mutat 30:857–859

    Article  PubMed  CAS  Google Scholar 

  12. Nagel M, Nagorka S, Gross O (2005) Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat 26:60

    Article  PubMed  Google Scholar 

  13. van der Loop FT, Heidet L, Timmer ED et al (2000) Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 58:1870–1875

    Article  PubMed  Google Scholar 

  14. Barker DF, Denison JC, Atkin CL et al (1997) Common ancestry of three Ashkenazi-American families with Alport syndrome and COL4A5 R1677Q. Hum Genet 99:681–684

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jane W. Kimani .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kimani, J.W., Weck, K.E. (2011). Alport Syndrome. In: Schrijver, I. (eds) Diagnostic Molecular Pathology in Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19677-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-19677-5_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19676-8

  • Online ISBN: 978-3-642-19677-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics